<div id="readability-page-1"><p><span>Morgan Stanley (NYSE:MS - Get Free Report)</span> had its price target upped by analysts at CICC Research  from $175.00 to $200.00 in a report issued on Tuesday,MarketScreener reports. The brokerage presently has an &#34;outperform&#34; rating on the financial services provider's stock. CICC Research's target price suggests a potential upside of 4.49% from the company's previous close.</p><div><p><span></span><span>Get <strong>Morgan Stanley</strong> alerts:</span></p></div><ul><li>How Williams Companies Is Cashing in on the AI Power Boom</li></ul><p>MS has been the subject of several other reports. JPMorgan Chase &amp; Co. increased their price objective on Morgan Stanley from $173.00 to $179.00 and gave the stock a &#34;neutral&#34; rating in a report on Tuesday, March 10th. Citigroup boosted their target price on Morgan Stanley from $170.00 to $194.00 and gave the company a &#34;neutral&#34; rating in a research note on Friday, May 8th. Dbs Bank raised their price target on Morgan Stanley from $185.00 to $220.00 in a research note on Thursday, May 7th. Wall Street Zen upgraded Morgan Stanley from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Friday, January 23rd. Finally, Wells Fargo &amp; Company increased their price objective on Morgan Stanley from $189.00 to $200.00 and gave the stock an &#34;equal weight&#34; rating in a report on Thursday, April 16th. One equities research analyst  has rated the stock with a Strong Buy rating, twelve have issued  a Buy rating and eleven have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $205.95.</p><p><b>Read Our Latest Report on MS</b></p><h2>Morgan Stanley Stock Down 0.7%</h2><ul><li>Big Bank Earnings Gave Financials a Lift, But Wall Street Is Still Cautious</li></ul><p>NYSE:MS traded down $1.28 on Tuesday, hitting $191.41. 338,752 shares of the company's stock traded hands, compared to its average volume of 6,794,800. The company has a current ratio of 0.77, a quick ratio of 0.77 and a debt-to-equity ratio of 3.52. The company has a market cap of $301.91 billion, a PE ratio of 17.30, a price-to-earnings-growth ratio of 1.45 and a beta of 1.22. The firm has a 50-day moving average price of $176.15 and a 200-day moving average price of $175.16. Morgan Stanley has a 1 year low of $123.88 and a 1 year high of $197.50. </p><p>Morgan Stanley (NYSE:MS - Get Free Report) last released its quarterly earnings data on Wednesday, April 15th. The financial services provider reported $3.43 earnings per share for the quarter, beating the consensus estimate of $3.02 by $0.41. The firm had revenue of $20.58 billion for the quarter, compared to analyst estimates of $19.23 billion. Morgan Stanley had a net margin of 14.65% and a return on equity of 17.70%. The company's revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.60 EPS.  Equities analysts anticipate that  Morgan Stanley will post 11.85 EPS for the current fiscal year. </p><h2>Insider Activity at Morgan Stanley</h2><ul><li>Stifel Financial: A Wealth Manager’s Stock for Wealth Investors</li></ul><p>In other Morgan Stanley news, insider Daniel A. Simkowitz sold 14,690 shares of the stock in a transaction that occurred on Friday, April 17th. The stock was sold at an average price of $189.24, for a total transaction of $2,779,935.60. Following the transaction, the insider owned 365,802 shares in the company, valued at $69,224,370.48. This trade represents a 3.86% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Eric F. Grossman sold 11,118 shares of Morgan Stanley stock in a transaction that occurred on Monday, April 20th. The shares were sold at an average price of $190.75, for a total transaction of $2,120,758.50. Following the completion of the transaction, the insider directly owned 169,403 shares in the company, valued at approximately $32,313,622.25. This represents a 6.16% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 77,476 shares of company stock valued at $14,644,762. Corporate insiders own  0.17% of the company's stock. </p><h2>Institutional Inflows and Outflows</h2><p>A number of hedge funds and other institutional investors have recently bought and sold shares of MS. Norges Bank bought a new position in shares of  Morgan Stanley in the fourth quarter worth about $2,736,648,000.  Price T Rowe Associates Inc. MD boosted its stake in  Morgan Stanley by 29.1% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 14,917,776 shares of the financial services provider's stock valued at $2,648,354,000 after purchasing an additional 3,364,080 shares during the period.  Corient Private Wealth LLC grew its holdings in  Morgan Stanley by 142.4% in the 4th quarter. Corient Private Wealth LLC now owns 3,122,060 shares of the financial services provider's stock valued at $511,723,000 after buying an additional 1,833,844 shares during the last quarter.  Vanguard Group Inc. grew its holdings in  Morgan Stanley by 1.2% in the 4th quarter. Vanguard Group Inc. now owns 119,718,100 shares of the financial services provider's stock valued at $21,253,554,000 after buying an additional 1,361,940 shares during the last quarter.  Finally, Thrivent Financial for Lutherans increased its position in  Morgan Stanley by 2,332.9% in the 4th quarter. Thrivent Financial for Lutherans now owns 1,406,495 shares of the financial services provider's stock worth $249,710,000 after buying an additional 1,348,683 shares during the period. 84.19% of the stock is currently owned by institutional investors and hedge funds. </p><h2>Key Headlines Impacting Morgan Stanley</h2><p>Here are the key news stories impacting Morgan Stanley this week:</p><ul>   <li><span>Neutral Sentiment: </span>Morgan Stanley strategists warned that equities could be vulnerable to a significant correction if the global bond rout worsens, citing heightened macro risk around the AI-led rally. <i></i><span>Morgan Stanley’s Wilson Warns Stock Rally at Risk From Bond Rout</span></li>   <li><span>Positive Sentiment: </span>Morgan Stanley reiterated a bullish stance on equities, pointing to AI growth and labor-market resilience as offsetting forces, which supports the view that the firm still sees upside in risk assets over time. <i></i><span>Morgan Stanley Remains Bullish on Equities While Flagging Recession Risks Ahead</span></li>   <li><span>Neutral Sentiment: </span>The broader market is also focused on Morgan Stanley commentary around Nvidia and AI-related capex, reinforcing that MS is closely tied to investor debate over whether AI spending can keep powering markets.</li> </ul><h2>Morgan Stanley Company Profile</h2> (Get Free Report)<p>Morgan Stanley <span>NYSE: MS<span></span></span> is a global financial services firm headquartered in New York City. Founded in 1935 by Henry S. Morgan and Harold Stanley, the company provides a broad range of investment banking, securities, wealth management and investment management services to corporations, governments, institutions and individual investors. Leadership has been guided by a senior executive team and board of directors; James P. Gorman has served as the company's chief executive and chairman in recent years.  </p><p>The firm's primary business activities are organized around three principal businesses: Institutional Securities, Wealth Management and Investment Management.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Morgan Stanley</li><li>Rewiring AI: NextEra Energy Sparks a Mega Merger</li><li>Flipping the Switch: Is Ford the Next Big Energy Stock?</li><li>Does Nano Nuclear Energy’s New Deal Amp the Outlook?</li><li>3 Dividend Stocks With Insiders Buying in 2026</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1T?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1T"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Morgan Stanley Right Now?</h2><p>Before you consider Morgan Stanley, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morgan Stanley wasn't on the list.</p><p>While Morgan Stanley currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

MSLC

<p>CICC Research has raised its price target for Morgan Stanley (NYSE:MS) from $175.00 to $200.00, maintaining an 'outperform' rating. This suggests a potential upside of 4.49% from the previous close. Other analysts have also adjusted their targets, with a consensus rating of 'Moderate Buy' and an average price target of $205.95. Morgan Stanley's stock recently traded at $191.41, down 0.7%. The company reported strong quarterly earnings, exceeding estimates with $3.43 EPS.</p>

Market Beat

Morgan Stanley

VG Financial

Morgan Stanley Pathway Large Cap Eq ETF

Calvert US Large-Cap Diversity Equity & Inclusion Index ETF

Parametric Hedged Equity ETF

Calvert US Mid-Cap Core Responsible Index ETF

Fidelity MSCI Financials Index

Calvert US Select Equity ETF

ISHRS Us Brokers & Sec Exchg

Calvert Ultra-Short Investment Grade ETF

Eaton Vance Intermediate Municipal Income ETF

Calvert US Large-Cap Core Responsible Index ETF

Eaton Vance Ultra-Short Income ETF

Financial Select Sector SPDR Fund

Eaton Vance High Yield ETF

Calvert International Responsible Index ETF

Morgan Stanley Pathway Sm-Md Cp Eq ETF

Parametric Equity Plus ETF

Parametric Equity Premium Income ETF

CICC

Williams

JPMorgan Chase

Citigroup

Wells Fargo

Stifel Financial

T. Rowe Price

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

CITIGROUP INC 6.250 NON CUM SER II PFD WI

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

STIFEL FINANCIAL CORP 6.125% DEP SHS REP 1/1000 NON CU PF SR C

Stifel Financial Pref Share SFB 5.2 10/15/47

STIFEL FINANCIAL CORP 6.25%NON CUM DEP SHS REP 1/1000TH SER B

STIFEL FINANCIAL CORP 4.50% DEP SHS REP 1/1000TH PREF SHS SR D

Morgan Stanley (NYSE:MS) Price Target Raised to $200.00